Delivery Order SPE2DB20D2014-SPE2DB24FD08J
Award Date
9/19/24
Potential Completion Date
9/20/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,218.74, is for the delivery of Briviact 10 mg/ml oral solution in 300 ml containers. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of March 10, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,215.40 firm fixed-price delivery order is for the pharmaceutical product Briviact 100 mg tablet 60s. The contract has an ultimate completion date of October 24, 2024 and was awarded on October 23, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide 60 tablets of the medication Briviact 50 mg. The firm-fixed-price delivery order is valued at $4,964.40 and has a completion date of March 24, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $2,558.34 Firm Fixed Price delivery order is for the supply of Briviact 10 mg/ml oral solution in 300 ml bottles. This order is not associated with a set-aside program and has an ultimate completion date of August 12, 2024. Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and...
This federal contract award to AmerisourceBergen Drug Corp is for the supply of Briviact 10 mg/ml oral solution (300 ml) to the Defense Logistics Agency (DLA), a defense agency. The firm-fixed-price delivery order has a ceiling value of $4,975.74 and a completion date of September 26, 2023. The contract is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $5,386.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product, under a Firm Fixed Price contract type. The contract has an ultimate completion date of September 5, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $1,252.41, is for the supply of 60 tablets of the pharmaceutical drug Briviact 50 mg. The contract is a firm fixed price arrangement and does not have a set-aside designation. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this order is part...
This federal contract award, valued at $13,295.70, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is a delivery order for the supply of 4,565,946 units of the pharmaceutical product BRIVIACT 25 MG TABLET 60S. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999, which enables the agency to...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is a delivery order valued at $2,885.47 for the supply of 60 tablets of the prescription drug BRIVIACT 100 MG. The contract was awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation. AmerisourceBergen is one of the largest pharmaceutical distributors in the United States and has extensive experience supplying a wide range of medical products and pharmaceuticals to federal...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is for the delivery of Briviact 100 mg tablets. The $3,410.56 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which provides medical supplies and pharmaceuticals to the U.S. Department of Defense. The contract has an ultimate completion date of March 19, 2024 and does not have a set-aside...